State Street’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $334M | Sell |
5,998,486
-254,237
| -4% | -$13.8M | 0.01% | 709 |
|
|
2025
Q4 | $309M | Sell |
6,252,723
-369,228
| -6% | -$17.2M | 0.01% | 739 |
|
|
2025
Q3 | $289M | Sell |
6,621,951
-92,272
| -1% | -$3.6M | 0.01% | 757 |
|
|
2025
Q2 | $261M | Sell |
6,714,223
-258,775
| -4% | -$9.89M | 0.01% | 767 |
|
|
2025
Q1 | $273M | Sell |
6,972,998
-52,095
| -0.7% | -$1.91M | 0.01% | 725 |
|
|
2024
Q4 | $240M | Buy |
7,025,093
+247,172
| +4% | +$8.9M | 0.01% | 831 |
|
|
2024
Q3 | $280M | Sell |
6,777,921
-24,359
| -0.4% | -$997K | 0.01% | 735 |
|
|
2024
Q2 | $264M | Sell |
6,802,280
-156,671
| -2% | -$6.59M | 0.01% | 719 |
|
|
2024
Q1 | $301M | Sell |
6,958,951
-94,039
| -1% | -$3.88M | 0.01% | 680 |
|
|
2023
Q4 | $264M | Sell |
7,052,990
-5,049
| -0.1% | -$181K | 0.01% | 705 |
|
|
2023
Q3 | $258M | Sell |
7,058,039
-186,654
| -3% | -$6.62M | 0.01% | 658 |
|
|
2023
Q2 | $261M | Sell |
7,244,693
-185,820
| -3% | -$6.67M | 0.01% | 672 |
|
|
2023
Q1 | $267M | Buy |
7,430,513
+9,173
| +0.1% | +$321K | 0.02% | 659 |
|
|
2022
Q4 | $263M | Sell |
7,421,340
-145,221
| -2% | -$4.84M | 0.02% | 657 |
|
|
2022
Q3 | $225M | Buy |
7,566,561
+760,637
| +11% | +$28.8M | 0.01% | 692 |
|
|
2022
Q2 | $373M | Sell |
6,805,924
-389,999
| -5% | -$21.5M | 0.02% | 552 |
|
|
2022
Q1 | $397M | Sell |
7,195,923
-10,458
| -0.1% | -$568K | 0.02% | 603 |
|
|
2021
Q4 | $402M | Sell |
7,206,381
-56,847
| -0.8% | -$2.96M | 0.02% | 594 |
|
|
2021
Q3 | $352M | Sell |
7,263,228
-67,410
| -0.9% | -$3.39M | 0.02% | 615 |
|
|
2021
Q2 | $370M | Sell |
7,330,638
-168,477
| -2% | -$8.1M | 0.02% | 625 |
|
|
2021
Q1 | $340M | Sell |
7,499,115
-109,161
| -1% | -$4.95M | 0.02% | 611 |
|
|
2020
Q4 | $355M | Buy |
7,608,276
+96,090
| +1% | +$4.41M | 0.02% | 573 |
|
|
2020
Q3 | $358M | Buy |
7,512,186
+58,485
| +0.8% | +$2.93M | 0.02% | 516 |
|
|
2020
Q2 | $384M | Buy |
7,453,701
+155,301
| +2% | +$7.97M | 0.03% | 494 |
|
|
2020
Q1 | $351M | Buy |
7,298,400
+999
| +0% | +$53.3K | 0.03% | 457 |
|
|
2019
Q4 | $433M | Sell |
7,297,401
-243,377
| -3% | -$13.5M | 0.03% | 498 |
|
|
2019
Q3 | $407M | Sell |
7,540,778
-220,146
| -3% | -$11.3M | 0.03% | 498 |
|
|
2019
Q2 | $393M | Sell |
7,760,924
-15,579
| -0.2% | -$782K | 0.03% | 510 |
|
|
2019
Q1 | $412M | Sell |
7,776,503
-130,209
| -2% | -$6.51M | 0.03% | 477 |
|
|
2018
Q4 | $382M | Sell |
7,906,712
-40,174
| -0.5% | -$1.98M | 0.03% | 456 |
|
|
2018
Q3 | $399M | Sell |
7,946,886
-53,132
| -0.7% | -$2.7M | 0.03% | 488 |
|
|
2018
Q2 | $403M | Sell |
8,000,018
-89,597
| -1% | -$4.51M | 0.03% | 470 |
|
|
2018
Q1 | $395M | Sell |
8,089,615
-119,791
| -1% | -$5.58M | 0.03% | 475 |
|
|
2017
Q4 | $364M | Sell |
8,209,406
-40,842
| -0.5% | -$1.89M | 0.03% | 506 |
|
|
2017
Q3 | $419M | Sell |
8,250,248
-19,038
| -0.2% | -$966K | 0.04% | 457 |
|
|
2017
Q2 | $446M | Sell |
8,269,286
-123,753
| -1% | -$6.6M | 0.04% | 435 |
|
|
2017
Q1 | $442M | Sell |
8,393,039
-87,624
| -1% | -$4.45M | 0.04% | 438 |
|
|
2016
Q4 | $408M | Buy |
8,480,663
+144,454
| +2% | +$7.14M | 0.04% | 439 |
|
|
2016
Q3 | $449M | Sell |
8,336,209
-41,887
| -0.5% | -$2.3M | 0.05% | 397 |
|
|
2016
Q2 | $454M | Buy |
8,378,096
+89,079
| +1% | +$4.69M | 0.05% | 382 |
|
|
2016
Q1 | $420M | Buy |
8,289,017
+19,398
| +0.2% | +$966K | 0.05% | 399 |
|
|
2015
Q4 | $417M | Sell |
8,269,619
-46,800
| -0.6% | -$2.39M | 0.05% | 394 |
|
|
2015
Q3 | $400M | Sell |
8,316,419
-81,902
| -1% | -$4.26M | 0.05% | 388 |
|
|
2015
Q2 | $437M | Sell |
8,398,321
-130,149
| -2% | -$7.33M | 0.05% | 380 |
|
|
2015
Q1 | $492M | Sell |
8,528,470
-46,231
| -0.5% | -$2.65M | 0.05% | 368 |
|
|
2014
Q4 | $458M | Sell |
8,574,701
-60,294
| -0.7% | -$3.37M | 0.05% | 394 |
|
|
2014
Q3 | $496M | Sell |
8,634,995
-13,001
| -0.2% | -$797K | 0.05% | 350 |
|
|
2014
Q2 | $578M | Sell |
8,647,996
-57,643
| -0.7% | -$3.9M | 0.06% | 318 |
|
|
2014
Q1 | $581M | Sell |
8,705,639
-31,659
| -0.4% | -$2.14M | 0.07% | 304 |
|
|
2013
Q4 | $583M | Sell |
8,737,298
-106,492
| -1% | -$6.91M | 0.06% | 314 |
|
|
2013
Q3 | $555M | Sell |
8,843,790
-116,701
| -1% | -$7.51M | 0.07% | 307 |
|
|
2013
Q2 | $560M | Buy |
+8,960,491
| New | +$569M | 0.07% | 281 |
|
Other funds holding GSK
JEST
State Street's GSK Position: Q1 2026 in Review
State Street reduced its GSK (GSK) stake by 4.1% in Q1 2026, selling an estimated $13.8M and leaving 5,998,486 shares worth $334M. The position accounts for 0.01% of the portfolio, ranked #709.
State Street first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $583M in Q4 2013. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- State Street held 5,998,486 shares of GSK worth $334M as of Q1 2026.
- State Street sold 254,237 GSK shares in Q1 2026, an estimated $13.8M.
- GSK made up 0.01% of State Street's portfolio in Q1 2026, its #709 holding.
- State Street first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
- State Street's GSK position peaked at $583M in Q4 2013.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.